Similarly, in the combined case-control and cohort study by Wium-Andersen and colleagues, 33 low doses of metformin, DPP-4 inhibitors, GLP-1 analogs, and SGLT2 inhibitors were associated with a lower risk of depression in patients with diabetes compared to non users, with the lowest risk for sodium-glucose transport protein 2 inhibitor users
books, ebooks, audio books and similar subscriptions
Gut microbiota alterations are not only implicated in SLE pathogenesis but may also offer novel biomarkers for early diagnosis
Functional medicine: We assess metabolic drivers of impaired healingglycemic control, micronutrient status (e.g., vitamin D, zinc), inflammatory load, sleep, and stress
Nakamura, T., Naguro, I
The FDA has issued safety communications regarding compounded GLP-1 receptor agonists, including tirzepatide and semaglutide, warning about adverse events from bacterial contamination, incorrect dosing, and use of improper ingredients
